In this first episode of a 2-part series, expert faculty provide key insights and take questions from healthcare professionals on aspects of influenza management in high-risk patients during the COVID-19 pandemic including diagnostic, prevention, and antiviral treatment strategies. Claim your credit at pce.is/flu.
Influenza management continues to increase in complexity as new diagnostic, prevention, and treatment options emerge and the COVID-19 pandemic adds additional considerations. Antiviral therapies for influenza now include neuraminidase inhibitors (eg, oseltamivir) and baloxavir. In this podcast, Lawrence Herman, DMSc, MPA, PA-C, asks timely influenza questions from healthcare professionals to infectious disease expert, Tracy Zivin-Tutela, MD. This activity is available for CE/CME credit. Claim your credit at pce.is/flu.